Lista de obras - Hugo Arasanz - Dominio Público Uruguay

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

artículo científico publicado en 2015

Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography.

artículo científico publicado en 2018

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics

artículo científico publicado en 2020

Immunotherapy in malignant melanoma: recent approaches and new perspectives

artículo científico publicado en 2017

Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy

artículo científico publicado en 2017

Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives

artículo científico publicado en 2017

Novel immunotherapies for the treatment of melanoma.

artículo científico publicado en 2016

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer ⬇️

article

PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy

artículo científico publicado en 2020

PD1 signal transduction pathways in T cells.

artículo científico publicado en 2017

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

artículo científico publicado en 2017

Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition

artículo científico publicado en 2020

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies

artículo científico publicado en 2020

Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapy

scientific article published on 10 July 2020

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies

artículo científico publicado en 2018

The intracellular signalosome of PD-L1 in cancer cells

artículo científico publicado en 2018

[Highly aggressive pulmonary epithelioid hemangioendothelioma: a case report]

scientific article published on 31 August 2017

Lista de obras de Hugo Arasanz

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography.

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics

Immunotherapy in malignant melanoma: recent approaches and new perspectives

Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy

Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives

Novel immunotherapies for the treatment of melanoma.

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer ⬇️

PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy

PD1 signal transduction pathways in T cells.

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies

Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapy

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies

The intracellular signalosome of PD-L1 in cancer cells

[Highly aggressive pulmonary epithelioid hemangioendothelioma: a case report]